# Flanigans Enterprises Inc: financial statements, quarterly

BDL · NYSE · CIK 12040 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/bdl.md) · [Financials](/companies/bdl/financials.md) · [Filings](/companies/bdl/filings.md) · [Insiders](/companies/bdl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [43.4](/filings/0001174947-24-001397.md) | [44.9](/filings/0001174947-25-001463.md) | [47.8](/filings/0001174947-25-001463.md) | [48.8](/filings/0001174947-25-001463.md) | [45.7](/filings/0001174947-25-001463.md) | [50.0](/filings/0001174947-26-000150.md) | [53.4](/filings/0001174947-26-000581.md) | [51.9](/filings/0001174947-26-000790.md) | [50.0](/filings/0001174947-25-001463.md) | [52.6](/filings/0001174947-26-000150.md) | [56.5](/filings/0001174947-26-000581.md) | [56.2](/filings/0001174947-26-000790.md) |
| Selling, general and administrative | $m | [1.8 d](/filings/0001174947-24-001397.md) | [1.2](/filings/0001174947-25-000152.md) | [1.4](/filings/0001174947-25-000783.md) | [1.3](/filings/0002077096-25-000008.md) | [1.4 d](/filings/0001174947-25-001463.md) | [1.5](/filings/0001174947-26-000150.md) | [1.4](/filings/0001174947-26-000581.md) | [1.1](/filings/0001174947-26-000790.md) | [1.5 d](/filings/0001174947-25-001463.md) | [1.4](/filings/0001174947-26-000150.md) | [1.5](/filings/0001174947-26-000581.md) | [1.4](/filings/0001174947-26-000790.md) |
| Operating income | $m | [0.4](/filings/0001174947-24-001397.md) | [0.7](/filings/0001174947-25-001463.md) | [2.5](/filings/0001174947-25-001463.md) | [2.1](/filings/0001174947-25-001463.md) | [0.5](/filings/0001174947-25-001463.md) | [0.8](/filings/0001174947-26-000150.md) | [3.5](/filings/0001174947-26-000581.md) | [2.9](/filings/0001174947-26-000790.md) | [1.6](/filings/0001174947-25-001463.md) | [1.7](/filings/0001174947-26-000150.md) | [4.2](/filings/0001174947-26-000581.md) | [4.0](/filings/0001174947-26-000790.md) |
| Interest expense | $m | [0.3 d](/filings/0001174947-23-001489.md) | [0.3](/filings/0001174947-24-000211.md) | [0.3](/filings/0001174947-24-000746.md) | [0.3](/filings/0002077096-25-000008.md) | [0.3 d](/filings/0001174947-25-001463.md) | [0.3](/filings/0001174947-26-000150.md) | [0.2](/filings/0001174947-26-000581.md) | [0.2](/filings/0001174947-26-000790.md) | [0.2 d](/filings/0001174947-25-001463.md) | [0.3](/filings/0001174947-26-000150.md) | [0.2](/filings/0001174947-26-000581.md) | [0.4](/filings/0001174947-26-000790.md) |
| Income tax | $m | [0.2 d](/filings/0001174947-24-001397.md) | [(0.0)](/filings/0001174947-25-000152.md) | [(0.1)](/filings/0001174947-25-000783.md) | [0.3](/filings/0002077096-25-000008.md) | [0.1 d](/filings/0001174947-25-001463.md) | [0.0](/filings/0001174947-26-000150.md) | [0.3](/filings/0001174947-26-000581.md) | [0.2](/filings/0001174947-26-000790.md) | [0.0 d](/filings/0001174947-25-001463.md) | [0.1](/filings/0001174947-26-000150.md) | [0.4](/filings/0001174947-26-000581.md) | [0.3](/filings/0001174947-26-000790.md) |
| Net income | $m | [(0.1)](/filings/0001174947-24-001397.md) | [0.1](/filings/0001174947-25-001463.md) | [1.9](/filings/0001174947-25-001463.md) | [1.1](/filings/0001174947-25-001463.md) | [0.2](/filings/0001174947-25-001463.md) | [0.1](/filings/0001174947-26-000150.md) | [2.7](/filings/0001174947-26-000581.md) | [1.4](/filings/0001174947-26-000790.md) | [0.9](/filings/0001174947-25-001463.md) | [0.8](/filings/0001174947-26-000150.md) | [2.9](/filings/0001174947-26-000581.md) | [2.1](/filings/0001174947-26-000790.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001174947-24-001397.md) | [0.06](/filings/0001174947-25-001463.md) | [1.04](/filings/0001174947-25-001463.md) | [0.60](/filings/0001174947-25-001463.md) | [0.10](/filings/0001174947-25-001463.md) | [0.03](/filings/0001174947-26-000150.md) | [1.45](/filings/0001174947-26-000581.md) | [0.75](/filings/0001174947-26-000790.md) | [0.48](/filings/0001174947-25-001463.md) | [0.43](/filings/0001174947-26-000150.md) | [1.55](/filings/0001174947-26-000581.md) | [1.11](/filings/0001174947-26-000790.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0001174947-24-001397.md) | [0.06](/filings/0001174947-25-001463.md) | [1.04](/filings/0001174947-25-001463.md) | [0.60](/filings/0001174947-25-001463.md) | [0.10](/filings/0001174947-25-001463.md) | [0.03](/filings/0001174947-26-000150.md) | [1.45](/filings/0001174947-26-000581.md) | [0.75](/filings/0001174947-26-000790.md) | [0.48](/filings/0001174947-25-001463.md) | [0.43](/filings/0001174947-26-000150.md) | [1.55](/filings/0001174947-26-000581.md) | [1.11](/filings/0001174947-26-000790.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [35.3](/filings/0001174947-24-001397.md) | [36.2](/filings/0001174947-24-000211.md) | [34.1](/filings/0001174947-24-000746.md) | [33.3](/filings/0001174947-24-001006.md) | [31.5](/filings/0001174947-25-001463.md) | [37.0](/filings/0001174947-25-000152.md) | [34.2](/filings/0001174947-25-000783.md) | [30.3](/filings/0002077096-25-000008.md) | [30.6](/filings/0001174947-26-000790.md) | [33.0](/filings/0001174947-26-000150.md) | [34.4](/filings/0001174947-26-000581.md) | [40.2](/filings/0001174947-26-000790.md) |
| Total assets | $m | [146](/filings/0001174947-24-001397.md) | [146](/filings/0001174947-24-000211.md) | [144](/filings/0001174947-24-000746.md) | [143](/filings/0001174947-24-001006.md) | [142](/filings/0001174947-25-001463.md) | [147](/filings/0001174947-25-000152.md) | [143](/filings/0001174947-25-000783.md) | [141](/filings/0002077096-25-000008.md) | [141](/filings/0001174947-26-000790.md) | [142](/filings/0001174947-26-000150.md) | [145](/filings/0001174947-26-000581.md) | [158](/filings/0001174947-26-000790.md) |
| Current liabilities | $m | [22.4](/filings/0001174947-24-001397.md) | [24.3](/filings/0001174947-24-000211.md) | [21.9](/filings/0001174947-24-000746.md) | [21.3](/filings/0001174947-24-001006.md) | [19.9](/filings/0001174947-25-001463.md) | [25.4](/filings/0001174947-25-000152.md) | [20.3](/filings/0001174947-25-000783.md) | [18.3](/filings/0002077096-25-000008.md) | [18.1](/filings/0001174947-26-000790.md) | [20.1](/filings/0001174947-26-000150.md) | [18.7](/filings/0001174947-26-000581.md) | [19.7](/filings/0001174947-26-000790.md) |
| Total liabilities | $m | [70.9](/filings/0001174947-24-001397.md) | [71.8](/filings/0001174947-24-000211.md) | [68.4](/filings/0001174947-24-000746.md) | [67.1](/filings/0001174947-24-001006.md) | [66.7](/filings/0001174947-25-001463.md) | [71.2](/filings/0001174947-25-000152.md) | [65.4](/filings/0001174947-25-000783.md) | [62.4](/filings/0002077096-25-000008.md) | [61.5](/filings/0001174947-26-000790.md) | [62.3](/filings/0001174947-26-000150.md) | [62.1](/filings/0001174947-26-000581.md) | [73.3](/filings/0001174947-26-000790.md) |
| Long-term debt | $m | [21.8](/filings/0001174947-24-001397.md) | [21.5](/filings/0001174947-24-000211.md) | [21.2](/filings/0001174947-24-000746.md) | [20.8](/filings/0001174947-24-001006.md) | [20.5](/filings/0001174947-25-001463.md) | [20.2](/filings/0001174947-25-000152.md) | [19.8](/filings/0001174947-25-000783.md) | [19.5](/filings/0002077096-25-000008.md) | [19.1](/filings/0001174947-26-000790.md) | [18.7](/filings/0001174947-26-000150.md) | [18.3](/filings/0001174947-26-000581.md) | [29.4](/filings/0001174947-26-000790.md) |
| Current portion of debt | $m | [1.3](/filings/0001174947-24-001397.md) | [1.3](/filings/0001174947-24-000211.md) | [1.3](/filings/0001174947-24-000746.md) | [1.4](/filings/0001174947-24-001006.md) | [1.4](/filings/0001174947-25-001463.md) | [1.4](/filings/0001174947-25-000152.md) | [1.4](/filings/0001174947-25-000783.md) | [1.4](/filings/0002077096-25-000008.md) | [1.5](/filings/0001174947-26-000790.md) | [1.6](/filings/0001174947-26-000150.md) | [1.6](/filings/0001174947-26-000581.md) | [2.0](/filings/0001174947-26-000790.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [5,677](/filings/0001174947-26-000790.md) | not reported | not reported |
| Shareholders' equity | $m | [59.2](/filings/0001174947-24-001397.md) | [59.0](/filings/0001174947-24-000211.md) | [61.1](/filings/0001174947-24-000746.md) | [61.3](/filings/0001174947-24-001006.md) | [75.4](/filings/0002077096-25-000008.md) | [61.6](/filings/0001174947-25-000152.md) | [64.0](/filings/0001174947-25-000783.md) | [64.3](/filings/0002077096-25-000008.md) | [65.2](/filings/0001174947-26-000790.md) | [66.0](/filings/0001174947-26-000150.md) | [68.8](/filings/0001174947-26-000581.md) | [69.8](/filings/0001174947-26-000790.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,289 d](/filings/0001174947-24-001397.md) | [3,450](/filings/0001174947-25-000152.md) | [(1,317) d](/filings/0001174947-25-000783.md) | [3,086 d](/filings/0002077096-25-000008.md) | [1,411 d](/filings/0001174947-25-001463.md) | [7,701](/filings/0001174947-26-000150.md) | [(1,972) d](/filings/0001174947-26-000581.md) | [1,421 d](/filings/0001174947-26-000790.md) | [3,360 d](/filings/0001174947-25-001463.md) | [4,945](/filings/0001174947-26-000150.md) | [2,142 d](/filings/0001174947-26-000581.md) | [5,738 d](/filings/0001174947-26-000790.md) |
| Capital expenditure | $k | [636 d](/filings/0001174947-24-001397.md) | [660](/filings/0001174947-25-000152.md) | [859 d](/filings/0001174947-25-000783.md) | [891 d](/filings/0002077096-25-000008.md) | [1,035 d](/filings/0001174947-25-001463.md) | [736](/filings/0001174947-26-000150.md) | [984 d](/filings/0001174947-26-000581.md) | [3,179 d](/filings/0001174947-26-000790.md) | [931 d](/filings/0001174947-25-001463.md) | [472](/filings/0001174947-26-000150.md) | [881 d](/filings/0001174947-26-000581.md) | [9,279 d](/filings/0001174947-26-000790.md) |
| Dividends paid | $k | [0.0 d](/filings/0001174947-24-001397.md) | not reported | not reported | not reported | [0.0 d](/filings/0001174947-25-001463.md) | not reported | not reported | not reported | [0.0 d](/filings/0001174947-25-001463.md) | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,859](/filings/0001174947-24-001397.md) | [1,859](/filings/0001174947-25-001463.md) | [1,859](/filings/0001174947-25-001463.md) | [1,859](/filings/0001174947-25-001463.md) | [1,859](/filings/0001174947-25-001463.md) | [1,859](/filings/0001174947-26-000150.md) | [1,859](/filings/0001174947-26-000581.md) | [1,859](/filings/0001174947-26-000790.md) | [1,859](/filings/0001174947-25-001463.md) | [1,859](/filings/0001174947-26-000150.md) | [1,859](/filings/0001174947-26-000581.md) | [1,859](/filings/0001174947-26-000790.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,858,647 at 2026-08-10, from the cover of the [10-Q filed 2026-08-11](/filings/0001174947-26-000790.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.